3B Future Health Fund
The Helsinn Investment Fund is focused on early-stage investments in areas of high unmet patient need
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed 3B Future Health Fund Information
Geographic Data
Address: 7-9, Av. de Grande-Bretagne
City: Monaco
State: liguria
Zip: 98000
Country: IT
Financial Info
Stage:
Raised Last:
$0
Raised Total:$50M
Social
Facebook
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2018 | On Target Laboratories | Series B | 0 |
| 3/2021 | OncoResponse | Series C | 0 |
| 4/2018 | Fore Biotherapeutics | Venture Round | 6M |
| 9/2016 | QuantuMDx Group | Venture Round | 2.7M |
| 3/2021 | NeoPhore | Series B | 0 |
| 9/2022 | Roca Therapeutics | Seed Round | - |
| 10/2016 | OncoResponse | Series A | 7M |
| 6/2017 | QuantuMDx Group | Venture Round | 340.2k |
| 2/2019 | Gain Therapeutics | Series A | 2.8M |
| 3/2021 | On Target Laboratories | Series B | 21M |
| 7/2020 | iOnctura | Series A | 5.8M |
| 4/2023 | Geneos Therapeutics | Series A | 0 |
| 10/2021 | GenEp | Seed Round | 0 |
| 5/2022 | Domain Therapeutics | Series A | 0 |
| 11/2017 | QuantuMDx Group | Venture Round | 1.3M |
| 1/2023 | NeoPhore | Series B | 0 |
| 9/2018 | OncoResponse | Series B | 40M |
| 10/2022 | Sibylla Biotech | Series A | 0 |
| 4/2021 | GreenBone Ortho | Series B | 0 |
| 3/2022 | Kither Biotech | Series B | 0 |
| 3/2022 | Epsilogen | Series B | 0 |
| 5/2023 | OncoResponse | Venture Round | 0 |
| 1/2018 | Personal Genome Diagnostics | Series B | 75M |
| 9/2017 | Amal Therapeutics | Series B | 9.5M |
| 11/2018 | Amal Therapeutics | Series B | 32.6M |
| 5/2017 | Aadi | Series A | 23M |
| 7/2016 | MEI Pharma | Post-IPO Equity | 5M |
| 6/2017 | GreenBone Ortho | Venture Round | 9.4M |
| 4/2023 | Geneos Therapeutics | Series A | 0 |
| 1/2023 | NeoPhore | Series B | 0 |
| 10/2022 | Sibylla Biotech | Series A | 0 |
| 9/2022 | Roca Therapeutics | Seed Round | - |
| 5/2022 | Domain Therapeutics | Series A | 0 |
| 3/2022 | Kither Biotech | Series B | 0 |
| 3/2022 | Epsilogen | Series B | 0 |
| 10/2021 | GenEp | Seed Round | 0 |
| 4/2021 | GreenBone Ortho | Series B | 0 |
| 3/2021 | OncoResponse | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
